Results 11 to 20 of about 52,201 (157)
Progestogens in menopausal hormone therapy [PDF]
Menopause Review, 2015 Progestogens share one common effect: the ability to convert proliferative endometrium to its secretory form. In contrast, their biological activity is varied, depending on the chemical structure, pharmacokinetics, receptor affinity and different potency
Małgorzata Bińkowska, Jarosław Woroń
doaj +4 more sources
Hormone Therapy for Menopausal Symptoms [PDF]
Annals of Internal Medicine, 2018 Recent evaluations of the methods of key studies should not change how we advise women A recently published and much publicised paper by Shapiro and colleagues, the last in a series of four, evaluated the effects of hormone therapy on the risk of breast cancer.1 The authors of the four review articles applied epidemiological principles to the ...
Eileen E, Reynolds +3 more
+7 more sources
Case Reports in Women's Health, 2020 Patients with surgical menopause often present to their primary care provider with menopausal symptoms. Here we present an unusual case of palmar arch artery occlusion in a 55-year-old woman with primary Raynaudˈs disease taking oral combined menopausal ...
Cristina Llaneza-Suarez +2 more
doaj +1 more source
绝经激素治疗与卒中相关性的meta分析 Meta-analysis of the Association of Menopausal Hormone Therapy with Stroke
Zhongguo cuzhong zazhi, 2022 目的 评估绝经激素治疗与卒中发生之间的相关性。 方法 计算机检索PubMed、Embase和Cochrane图书馆从建库到2022年1月5日已经发表的关于绝经后女性采取绝经激素治疗的随机对照试验以及观察性研究，其中随机对照试验治疗方式必须为口服激素治疗，且随访的时间应超过6个月。探索绝经激素治疗与卒中之间的相关性，结局指标为研究人群的卒中发生率。 结果 绝经激素治疗随机对照试验的meta分析纳入了7项研究，35 776例健康女性中共有566例（1.58%）发生卒中，接受绝经激素治疗的18 ...
曹雨停，范文娟，王春雪，陈瑛
doaj +1 more source
Clinical consideration of two key questions in assessing menopausal status of female breast cancer patients [PDF]
Zhongguo aizheng zazhiEndocrine therapy plays a crucial role in hormone receptor-positive breast cancer and is closely related to the patient’s menopausal status. This manuscript aimed to explore two key questions in assessing menopausal status of breast cancer patients ...
Jian ZHANG
doaj +2 more sources
PLoS Medicine, 2011 BackgroundEven after the Women's Health Initiative (WHI) found that the risks of menopausal hormone therapy (hormone therapy) outweighed benefit for asymptomatic women, about half of gynecologists in the United States continued to believe that hormones ...
Adriane Fugh-Berman +4 more
doaj +1 more source
Menopausal hormone therapy: oncological risks
Лечащий Врач, 2021 The article presents generalized data on cancer risks during menopausal hormone therapy (MHT). It is shown that, in proper MHT prescription, it is possible to achieve targeted treatment outcomes without increasing cancer risk.
I. V. Madyanov, T. S. Madyanova
doaj
Hormone therapy for postmenopausal women
Репродуктивная эндокринология, 2020 Hormone therapy is recommended for relief from hot flashes or night sweats in women younger than age 60 years or those who entered menopause within 10 years of seeking treatment.
J. V. Pinkerton
doaj +1 more source
Alternatives of menopausal hormone therapy
Medicinski pregled, 2016 Introduction. It has been generally accepted that the benefits of menopausal hormone therapy outweigh the risks, but there are still some concerns about the administration of menopausal hormone therapy, which has introduced alternative treatments. Pharmacological Alternatives.
Ranko M, Kutlesic +5 more
openaire +3 more sources
Bioidentical Hormones for Menopausal Therapy [PDF]
Women's Health, 2008 'Bioidentical hormones' is a term created by the lay media to refer to chemicals derived from plants that are modified to be structurally identical to endogenous human hormones. These compounds include estradiol, estrone, estriol, progesterone, testosterone and dehydroepiandrosterone when prescribed for menopausal women.
openaire +2 more sources